penicillanic acid has been researched along with Kidney Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isami, K; Kawamata, Y; Kozono, A; Miyoshi, T; Sasaki, E; Senba, M; Tsumagari, K; Tsuruta, M; Yamashina, T; Yamashita, K | 1 |
| Deresinski, S; Watkins, RR | 1 |
| Burke, MJ; Pratt, JA; Stricherz, MK; Verghese, PS | 1 |
| Akers, KS; Cannon, JW; Chung, KK; Cota, JM; Murray, CK; Niece, KL | 1 |
| Hamaguchi, S; Ikawa, K; Ishihara, N; Karino, F; Kuraki, T; Miura, K; Morikawa, N; Moriyama, H; Nishimura, N; Sutani, A | 1 |
| Arah, OA; Chow, AL; Lye, DC | 1 |
| Mellen, CK; Rindone, JP; Ryba, JE | 1 |
| Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E | 1 |
| Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
| Wise, R; Wright, N | 1 |
| Green, EA; Hall, S; Hanna, CE; Sattler, FR | 1 |
| Guillaume, Y; Guinchard, C; Peyrin, E | 1 |
| Dalla Costa, T; Derendorf, H | 1 |
| de la Pena, A; Derendorf, H | 1 |
| Anastasio, P; Casoli, E; De Santo, NG; Molino, D | 1 |
| Amorusi, P; Dowell, JA; Korth-Bradley, J; Milisci, M; Tantillo, K; Tse, S | 1 |
| Denneberg, T; Ekberg, M; Juhlin, I; Larsson, S | 1 |
| Dutta, A; Faulkner, R; Greene, DS; Halstenson, CE; Haynes, J; Johnson, CA; Kelloway, JS; Shapiro, BE; Tonelli, A; Zimmerman, SW | 1 |
| Cushing, RD; Lerner, AM; Williams, BB | 1 |
| Agersborg, HP; Janssen, FW; Kirkman, SK; Ruelius, HW; Tucker, WE; Young, EM | 1 |
2 review(s) available for penicillanic acid and Kidney Diseases
| Article | Year |
|---|---|
Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Kidney Diseases; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Vancomycin | 2017 |
Pharmacokinetic properties of beta-lactamase inhibitors.
Topics: Absorption; Aging; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Biological Availability; Clavulanic Acid; Drug Synergism; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Sulbactam; Tazobactam | 1999 |
3 trial(s) available for penicillanic acid and Kidney Diseases
| Article | Year |
|---|---|
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infections.
Topics: Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Penicillanic Acid; Random Allocation; Tobramycin | 1983 |
Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment.
Topics: Adult; Aged; Aging; Anti-Bacterial Agents; Area Under Curve; beta-Lactamase Inhibitors; Creatinine; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Tobramycin | 2001 |
15 other study(ies) available for penicillanic acid and Kidney Diseases
| Article | Year |
|---|---|
Investigation of the Efficacy of an Administration Plan for Tazobactam/Piperacillin (TAZ/PIPC) and the Incidence of Kidney and Hepatic Disorders.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Creatinine; Drug Administration Schedule; Female; Humans; Incidence; Kidney Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2017 |
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?
Topics: Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Vancomycin | 2017 |
Suspected piperacillin-tazobactam induced nephrotoxicity in the pediatric oncology population.
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney Diseases; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis | 2014 |
Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Critical Illness; Cross-Sectional Studies; Female; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Wounds and Injuries; Young Adult | 2014 |
Nephrotoxicity induced by piperacillin–tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia.
Topics: Aged; Aged, 80 and over; Aging; Anti-Bacterial Agents; Asian People; Cross Infection; Female; Humans; Kidney Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial | 2014 |
Patient and physician predictors of patient receipt of therapies recommended by a computerized decision support system when initially prescribed broad-spectrum antibiotics: a cohort study.
Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Decision Support Systems, Clinical; Drug Therapy, Computer-Assisted; Drug Utilization; Female; Guideline Adherence; Humans; Inappropriate Prescribing; Intensive Care Units; Kidney Diseases; Male; Middle Aged; Patient Admission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Singapore | 2016 |
Lack of significant variability among different methods for calculating antimicrobial days of therapy.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin | 2012 |
The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction.
Topics: Ampicillin; Drug Combinations; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Sulbactam | 1983 |
High-performance liquid chromatographic determination of tazobactam by precolumn derivatization.
Topics: beta-Lactamase Inhibitors; Calibration; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Hemofiltration; Humans; Indicators and Reagents; Kidney Diseases; Penicillanic Acid; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tazobactam | 1995 |
Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment.
Topics: Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1996 |
Renal abscess: recovery without hospitalization and drainage.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Drainage; Female; Hospitalization; Humans; Kidney; Kidney Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Staphylococcal Infections; Ultrasonography | 2001 |
Pharmacokinetic and therapeutic studies of pivmecillinam in patients with normal and impaired renal function.
Topics: Acute Kidney Injury; Administration, Oral; Adolescent; Adult; Aged; Amdinocillin Pivoxil; Bacteriuria; Drug Evaluation; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Penicillanic Acid; Renal Dialysis; Urinary Tract Infections | 1978 |
Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease.
Topics: Adult; beta-Lactamase Inhibitors; Creatine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Renal Dialysis; Tazobactam; Time Factors | 1992 |
Letter: Severe combined nephrotoxicity of BL-P1654 and gentamicin.
Topics: Adult; Blood Bactericidal Activity; Carbenicillin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Humans; Kidney Diseases; Penicillanic Acid; Polymyxins; Pseudomonas aeruginosa; Sepsis | 1974 |
Metabolic and pathologic investigation of 1-aminocyclohexanecarboxylic acid (ACHC), a metabolite of 6-(1-aminocyclohexanecarboxamido)-penicillanic acid (cyclacillin).
Topics: Amino Acids; Animals; Cyclacillin; Cyclohexanecarboxylic Acids; Dogs; Female; Kidney Diseases; Male; Penicillanic Acid; Rats; Rats, Inbred Strains; Sex Factors | 1974 |